Personalised ASV therapy has never been easier

 

The AutoSet CS-A with PaceWave is ResMed’s most responsive ASV technology to stabilise the ventilation of adult patients exhibiting central breathing disorders such as Cheyne-Stokes respiration (associated with congestive heart failure), central sleep apnea (CSA), complex sleep apnea (CompSA) and mixed apnea with or without upper airway obstruction.

 

Clinically studied, ResMed's pioneering PaceWave technology is the only ASV therapy to target the patient’s own recent minute ventilation (MV). PaceWave monitors the entire breath with split-second resolution to learn and predict a patient’s unique breathing pattern, rapidly responding to changes and steadily keeping your patient on target throughout the night.

 

PaceWave rapidly stabilises breathing and blood gases helping improve sleep quality and reduce stress on the heart1.

 

Additionally, the AutoSet CS-A features the new ASVAuto mode with an automatically adjusting EPAP to automatically maintain an open upper airway.

 

It also provides greater peace of mind with four alarms to monitor your sensitive patients.

 

The comfort features of the S9 platform in combination with PaceWave’s ability to provide synchrony over a wider range of breath rates and personalised breathing, provides a new level of comfort supporting patient compliance.

 

Modes: CPAP, ASV and ASVAuto

 

Alarms: High leak, Non-Vented Mask, Low Minute Ventilation, Low SpO2

 

Technology features: PaceWave™

 

Platform features:

  • Climate Control, with the H5i heated humidifier and ClimateLineMAX tube, maintains ideal humidification according to real-time environment.
  • Easy-Breathe motor offers the quietest therapy available.
  • Easy-to-use controls and color LCD make menu navigation simple and intuitive.
  • SlimLine and ClimateLine tubes are exceptionally slim and lightweight, virtually eliminating tube drag.

 

1 Hastings, P.C., et al., Adaptive servo-ventilation in heart failure patients with sleep apnea: a real world study. Int J Cardiol, 2010. 139(1): p. 17-24.

©2000-2014 ResMed. All rights reserved.